BREAST CANCER

>

Latest News

FDA Issues Warning on BioZorb Markers After Recall Due to Patient Complications
FDA Issues Warning on BioZorb Markers After Recall Due to Patient Complications

October 30th 2024

Providers advised to halt use, monitor patients, and report any complications with BioZorb devices to the FDA.

Pembrolizumab Plus Chemotherapy Enhances Outcomes in Early-Stage TNBC
Pembrolizumab Plus Chemotherapy Enhances Outcomes in Early-Stage TNBC

October 30th 2024

Genetic Clues to Early-Onset TNBC in Black Women
Genetic Clues to Early-Onset TNBC in Black Women

October 29th 2024

AI Outperforms Standard HRD Tests  for Breast, Ovarian Cancers
AI Outperforms Standard HRD Tests for Breast, Ovarian Cancers

October 29th 2024

T-DXd Use in HER2+ Breast Cancer Influenced by Site of Metastases and AE Monitoring
T-DXd Use in HER2+ Breast Cancer Influenced by Site of Metastases and AE Monitoring

October 21st 2024

Latest CME Events & Activities

22nd Annual School of Breast Oncology

November 7-9, 2024

Register Now!

42nd Annual CFS: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Community Oncology Connections™: Controversies and Conversations About HER2-Expressing Breast Cancer… Advances in Management from HER2-Low to Positive Disease

View More

Emerging Treatments and Evolving Paradigms in HER2-Low Breast Cancer

View More

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

View More

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

View More

Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings

View More

School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio

View More

Annual Hawaii Cancer Conference

January 25-26, 2025

Register Now!

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

View More

42nd Annual Miami Breast Cancer Conference®

March 6 - 9, 2025

Register Now!

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Next-Generation Endocrine Therapy for ER+/HER2- Breast Cancer: Addressing Unmet Needs and Keys to Optimization in Clinical Practice

View More

Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions

View More

Empowering Breast Cancer Patients with Non-Opioid Pain Management Innovations

View More

Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Community Practice Connection™: Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

How We Do It™: Defining HER2 Low on Your Pathology Reports to Make Informed Decisions in Breast Cancer Treatment

View More

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

24th Annual International Congress on the Future of Breast Cancer® West

July 18-19, 2025

Register Now!

24th Annual International Congress on the Future of Breast Cancer® East

July 11-12, 2025

Register Now!

Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management

View More

Community Practice Connections™: 23rd Annual International Congress on the Future of Breast Cancer West

View More

School of Breast Oncology® (SOBO) Slide & Lecture Library

Joyce O’Shaughnessy, MD

View More

More News